Press release
Illumina advances NovaSeq X Series, delivering single-flow-cell system, software upgrade, and new kits to enable multiomic applications
Software upgrade advances complete workflow solutions New NovaSeq X 25B 100-cycle and 200-cycle kits enhance multiomic capabilities on NovaSeq X, and enable
About this update from Illumina, Inc.
[{"type":"text","content":"Software upgrade advances complete workflow solutions\nNew NovaSeq X 25B 100-cycle and 200-cycle kits enhance multiomic capabilities on NovaSeq X, and enable newly released Illumina Single-Cell Prep\nSAN DIEGO, Jan. 7, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a series of updates to its NovaSeq X Series, delivering the NovaSeq X single-flow-cell system alongside a cutting-edge software upgrade and new kits.\n\n \n \n \n \n \n \n\n \nNow in the market for the first time, the single-flow-cell NovaSeq X Sequencing System offers the same high-quality flow cells and speed as the NovaSeq X Plus Sequencing System—Illumina's most rapidly adopted and utilized high-throughput sequencing platform to date—at a more accessible cost for labs with lower volume. The sequencers began shipping in December, and simultaneously the company introduced the software v1.3 upgrade for the NovaSeq X Series to elevate sequencing performance and advance data quality. Additionally, new NovaSeq X 25B 100- and 200-cycle kits began shipping in December, which will be key enablers of multiomic applications, including the Illumina Single-Cell 3' RNA Prep (Illumina Single Cell Prep), now available under Illumina's brand following the company's acquisition of Fluent.\n\"This is the same instrument the scientific community has come to rely on for next-generation sequencing, now with upgraded software, new kits, and the option for a lower volume,\" said Steve Barnard, PhD, chief technology officer of Illumina. \"Based on customer input, we've invested heavily in innovations to make the platform even stronger and more versatile, supporting total workflows with flexible applications spanning genomics and multiomics. Customers are already raving about the powerful capabilities of the software upgrade.\"\nCustomers affirm the value of the software upgrade \nThe newly launched software upgrade delivers key enhancements that optimize sequencing workflows. Version 1.3 provides laboratories with improved sequencing accuracy and higher yields to ensure dependable and precise results, even with challenging, low-diversity samples. The reduction in PhiX dependency also means more usable data per run, helping researchers maximize their throughput and their confidence in their sequencing outp...